Literature DB >> 24074588

Human papillomavirus type 16 E7 oncoprotein inhibits the anaphase promoting complex/cyclosome activity by dysregulating EMI1 expression in mitosis.

Yueyang Yu1, Karl Munger.   

Abstract

The anaphase promoting complex/cyclosome (APC/C) is a ubiquitin ligase complex that orchestrates mitotic progression by targeting key mitotic regulators for proteasomal degradation. APC/C dysfunction is a frequent event during cancer development and can give rise to genomic instability. Here we report that the HPV16 E7 oncoprotein interferes with the degradation of APC/C substrates and that the APC/C inhibitor, EMI1, is expressed at higher levels in HPV16 E7-expressing mitotic cells. HPV16 E7 expression causes increased EMI1 mRNA expression and also inhibits EMI1 degradation. The resulting abnormally high EMI1 levels in HPV16 E7-expressing mitotic cells may inhibit degradation of APC/C substrates and cause the prometaphase delay that we have previously observed in such cells.
© 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Anaphase Promoting Complex/Cyclosome (APC/C); Cervical cancer; E7 oncoprotein; EMI1; Genomic instability; Human papillomaviruses; Mitosis

Mesh:

Substances:

Year:  2013        PMID: 24074588      PMCID: PMC3799973          DOI: 10.1016/j.virol.2013.08.013

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  67 in total

1.  High-risk but not low-risk HPV E2 proteins bind to the APC activators Cdh1 and Cdc20 and cause genomic instability.

Authors:  Sophie Bellanger; Stéphanie Blachon; Francisca Mechali; Catherine Bonne-Andrea; Françoise Thierry
Journal:  Cell Cycle       Date:  2005-11-29       Impact factor: 4.534

2.  Cyclin-dependent kinase (CDK) phosphorylation destabilizes somatic Wee1 via multiple pathways.

Authors:  Nobumoto Watanabe; Harumi Arai; Jun-Ichi Iwasaki; Masaaki Shiina; Kazuhiro Ogata; Tony Hunter; Hiroyuki Osada
Journal:  Proc Natl Acad Sci U S A       Date:  2005-08-05       Impact factor: 11.205

3.  The Rae1-Nup98 complex prevents aneuploidy by inhibiting securin degradation.

Authors:  Karthik B Jeganathan; Liviu Malureanu; Jan M van Deursen
Journal:  Nature       Date:  2005-12-15       Impact factor: 49.962

4.  Human papillomavirus type 16 E7 oncoprotein associates with E2F6.

Authors:  Margaret E McLaughlin-Drubin; Kyung-Won Huh; Karl Münger
Journal:  J Virol       Date:  2008-06-25       Impact factor: 5.103

5.  Human papillomavirus type 16 E7 oncoprotein associates with the centrosomal component gamma-tubulin.

Authors:  Christine L Nguyen; Catherine Eichwald; Max L Nibert; Karl Münger
Journal:  J Virol       Date:  2007-10-03       Impact factor: 5.103

6.  The ubiquitin ligase APC(Cdh1) is required to maintain genome integrity in primary human cells.

Authors:  D Engelbert; D Schnerch; A Baumgarten; R Wäsch
Journal:  Oncogene       Date:  2007-08-13       Impact factor: 9.867

7.  Genomic stability and tumour suppression by the APC/C cofactor Cdh1.

Authors:  Irene García-Higuera; Eusebio Manchado; Pierre Dubus; Marta Cañamero; Juan Méndez; Sergio Moreno; Marcos Malumbres
Journal:  Nat Cell Biol       Date:  2008-06-15       Impact factor: 28.824

8.  Human papillomavirus type 16 E7 oncoprotein associates with the cullin 2 ubiquitin ligase complex, which contributes to degradation of the retinoblastoma tumor suppressor.

Authors:  KyungWon Huh; Xiaobo Zhou; Hiroyuki Hayakawa; Je-Yoel Cho; Towia A Libermann; Jianping Jin; J Wade Harper; Karl Munger
Journal:  J Virol       Date:  2007-07-03       Impact factor: 5.103

9.  The END network couples spindle pole assembly to inhibition of the anaphase-promoting complex/cyclosome in early mitosis.

Authors:  Kenneth H Ban; Jorge Z Torres; Julie J Miller; Alexei Mikhailov; Maxence V Nachury; Jeffrey J Tung; Conly L Rieder; Peter K Jackson
Journal:  Dev Cell       Date:  2007-07       Impact factor: 12.270

10.  Emi1 is needed to couple DNA replication with mitosis but does not regulate activation of the mitotic APC/C.

Authors:  Barbara Di Fiore; Jonathon Pines
Journal:  J Cell Biol       Date:  2007-05-07       Impact factor: 10.539

View more
  8 in total

1.  The Rb binding domain of HPV31 E7 is required to maintain high levels of DNA repair factors in infected cells.

Authors:  Bryan A Johnson; Heather L Aloor; Cary A Moody
Journal:  Virology       Date:  2016-10-19       Impact factor: 3.616

Review 2.  Who guards the guardian? Mechanisms that restrain APC/C during the cell cycle.

Authors:  Jennifer Kernan; Thomas Bonacci; Michael J Emanuele
Journal:  Biochim Biophys Acta Mol Cell Res       Date:  2018-10-02       Impact factor: 4.739

3.  microRNAs' differential regulations mediate the progress of Human Papillomavirus (HPV)-induced Cervical Intraepithelial Neoplasia (CIN).

Authors:  Wenjuan Mo; Chao Tong; Yan Zhang; Hong Lu
Journal:  BMC Syst Biol       Date:  2015-02-07

Review 4.  The role of ubiquitin and ubiquitin-like modification systems in papillomavirus biology.

Authors:  Van G Wilson
Journal:  Viruses       Date:  2014-09-24       Impact factor: 5.048

5.  Stranglehold on the spindle assembly checkpoint: the human papillomavirus E2 protein provokes BUBR1-dependent aneuploidy.

Authors:  Chye Ling Tan; Sébastien Teissier; Jayantha Gunaratne; Ling Shih Quek; Sophie Bellanger
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

6.  SETD2-dependent H3K36me3 plays a critical role in epigenetic regulation of the HPV31 life cycle.

Authors:  Dipendra Gautam; Bryan A Johnson; Michelle Mac; Cary A Moody
Journal:  PLoS Pathog       Date:  2018-10-12       Impact factor: 6.823

Review 7.  Upsetting the Balance: When Viruses Manipulate Cell Polarity Control.

Authors:  Miranda Thomas; Lawrence Banks
Journal:  J Mol Biol       Date:  2018-04-20       Impact factor: 5.469

Review 8.  The Not-So-Good, the Bad and the Ugly: HPV E5, E6 and E7 Oncoproteins in the Orchestration of Carcinogenesis.

Authors:  Om Basukala; Lawrence Banks
Journal:  Viruses       Date:  2021-09-22       Impact factor: 5.048

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.